{"title":"减少剂量直接口服抗凝剂对伴有轻度血小板减少的心房颤动患者是安全的","authors":"M. Gross","doi":"10.22237/CRP/1567555920","DOIUrl":null,"url":null,"abstract":"<p>Janion-Sadowska A, Papuga-Szela E, Łukaszuk R, Chrapek M, Undas A. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia. <em>Journal of Cardiovascular Pharmacology</em>, 2018;72(3):153-160. doi: <a href=\"https://doi.org/10.1097/FJC.0000000000000607\">10.1097/FJC.0000000000000607</a></p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reduced doses of direct oral anticoagulation are safe in atrial fibrillation patients with mild thrombocytopenia\",\"authors\":\"M. Gross\",\"doi\":\"10.22237/CRP/1567555920\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Janion-Sadowska A, Papuga-Szela E, Łukaszuk R, Chrapek M, Undas A. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia. <em>Journal of Cardiovascular Pharmacology</em>, 2018;72(3):153-160. doi: <a href=\\\"https://doi.org/10.1097/FJC.0000000000000607\\\">10.1097/FJC.0000000000000607</a></p>\",\"PeriodicalId\":10422,\"journal\":{\"name\":\"Clinical Research In Practice: The Journal of Team Hippocrates\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Research In Practice: The Journal of Team Hippocrates\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22237/CRP/1567555920\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research In Practice: The Journal of Team Hippocrates","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22237/CRP/1567555920","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Reduced doses of direct oral anticoagulation are safe in atrial fibrillation patients with mild thrombocytopenia
Janion-Sadowska A, Papuga-Szela E, Łukaszuk R, Chrapek M, Undas A. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia. Journal of Cardiovascular Pharmacology, 2018;72(3):153-160. doi: 10.1097/FJC.0000000000000607
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
